Paul Hartmann AGSTU:PHH2 62 Quick Ratio is 1.21 as of Dec. 2025, which is 5% below its 10-year median of 1.28. GuruFocus rates STU:PHH2 with a GF Score™ of 62/100 and a GF Value™ of €229.60 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Paul Hartmann AG ranks worse than 68.5% on this metric.
Paul Hartmann AG has a quick ratio of 1.21. It generally indicates good short-term financial strength.
The historical rank and industry rank for Paul Hartmann AG's Quick Ratio or its related term are showing as below:
STU:PHH2'
s Quick Ratio Range Over the Past 10 Years
Min: 1.09 Med: 1.28 Max: 1.55
Current: 1.21
During the past 13 years, Paul Hartmann AG's highest Quick Ratio was 1.55. The lowest was 1.09. And the median was 1.28.
STU:PHH2's Quick Ratio is ranked worse than 68.5% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.885
vs STU:PHH2: 1.21
Paul Hartmann AG (STU:PHH2) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Paul Hartmann AG Quick Ratio Related Terms
Paul Hartmann AG Quick Ratio Historical Data
* Premium members only.
The historical data trend for Paul Hartmann AG's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:PHH2 vs ISRG, BDX, MDLN: Quick Ratio Comparison
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Paul Hartmann AG's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (STU:PHH2) has a Quick Ratio of 1.21 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Paul Hartmann AG and its competitors. This is near median its historical median of 1.28. Over the past decade, Paul Hartmann AG's Quick Ratio has ranged from 1.09 to 1.55. According to the industry distribution chart, Paul Hartmann AG ranks #585 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 68.5%.
Is Paul Hartmann AG's Quick Ratio too high?
Paul Hartmann AG's current Quick Ratio of 1.21 is near median its 10-year median of 1.28. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 1.55. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Paul Hartmann AG's value of 1.21 is 35.8% below this industry median. Based on the distribution chart, Paul Hartmann AG ranks #585 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Paul Hartmann AG has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Paul Hartmann AG ranks #585 out of 854 companies for Quick Ratio. This places Paul Hartmann AG in the lower half of its industry. The industry median Quick Ratio is 1.89. Paul Hartmann AG's value of 1.21 is 35.8% below this benchmark. Historically, Paul Hartmann AG's own Quick Ratio has ranged from 1.09 to 1.55 over the past decade. While the company's 10-year median is 1.28 vs. the industry median of 1.89, Paul Hartmann AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paul Hartmann AG's current Quick Ratio of 1.21 is 35.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Paul Hartmann AG and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paul Hartmann AG's current Quick Ratio is 1.21, which is near median its own 10-year median of 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (STU:PHH2) is currently considered Modestly Undervalued. The stock's GF Value™ is €229.60, compared to a current price of €204.00 — trading 11.1% below its estimated fair value. The current Quick Ratio is 1.21, which is near median its 10-year median of 1.28 and 35.8% below the Medical Devices & Instruments industry median of 1.89. Paul Hartmann AG's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Paul Hartmann AG (STU:PHH2), the current Quick Ratio is 1.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paul Hartmann AG (STU:PHH2) Overvalued in 2026?
Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued.
The current stock price of €204.00 is trading 11.1% below its estimated GF Value™ of €229.60.
GuruFocus considers Paul Hartmann AG to be Modestly Undervalued.
Key valuation signals for STU:PHH2:
Quick Ratio: 1.21 (near median its 10-year median of 1.28)
GF Value™: €229.60 vs. price of €204.00 (11.1% below fair value)
Industry Position: 35.8% below the Medical Devices & Instruments median (#585 of 854)
No single metric tells the full story. See the STU:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
62GF Score
Get the complete analysis for STU:PHH2
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:PHH2 has been successfully added to your 
